Key result
Breast cancer diagnosis in Black females is linked to ~24% higher incident CVD risk.
Why the study?
Little is known about whether a breast or gynecologic cancer diagnosis increases long-term cardiovascular disease risk among Black females.
Cohort (n=11,486)
Hazard Ratio: 1.24 (95% CI 1.11–1.39)
p-value: p=<0.001
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Cancer history, treatment-related toxicity and metabolic derangements, ASCVD risk factors, competing mortality, prognosis, and drug interactions must be incorporated into lipid-management decisions rather than treated as secondary considerations.”
Observational analysis reveals links between cardiovascular disease and gynecologic cancers in Black female patients, highlighting intersecting risks.
INTRODUCTION Little is known about whether a breast or gynecologic cancer diagnosis increases long-term cardiovascular disease (CVD) risk among Black females. The purpose of this study was to determine whether a breast or gynecologic cancer diagnosis is associated with CVD risk and identify determinants of subsequent CVD risk among Black females with an incident breast or gynecologic cancer diagnosis. METHODS Using the Southern Community Cohort Study data from 2002-2016, this study was designed to analyze CVD incidence among Black females without cancer or CVD at enrollment. Cox proportional hazards regression models with or without covariates were used to explore the relationship between a breast or gynecologic cancer diagnosis and CVD risk among women without cancer as well as without CVD at enrollment (N=11,486). In addition, Cox proportional hazards regression models, excluding those who developed CVD before breast and gynecologic cancer diagnosis and those with other types of cancers, were used to assess determinants of CVD risk among breast and gynecologic cancer survivors. RESULTS Of 11,486 Black females, 531 developed a breast or gynecological cancer (4.6%) over a median follow-up of 140 months (interquartile range: 123-159 months). Compared to women without cancer, women with a breast or gynecological cancers had greater than 20% higher risk of incident CVD during the follow-up period. Without adjusting for covariates, positive association between CVD risk and breast cancer was observed (hazard ratio (HR) = 1.24; 95% confidence interval (CI) = 1.11 - 1.39; p < 0.001); as well as between CVD risk and a gynecological cancer (HR = 1.23; 95% CI = 1.03 - 1.46; p = 0.021). Yet, after adjusting for covariates, CVD risk was only significantly associated with breast cancer (p = 0.001) but not gynecologic cancer. In cancer case-only analyses, CVD risk was significantly increasing with age (p < 0.05). CONCLUSIONS Like study populations of predominantly White females, our results suggest that, adjusting for covariates, Black females possess a higher risk of CVD following a breast cancer diagnosis compared to women who did not develop breast cancer. Our results suggest a need for active CVD surveillance in the cancer survivorship phase.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2023) conducted a cohort in Breast or gynecologic cancer (n=11,486). Breast cancer diagnosis vs. Women without cancer was evaluated on Incident cardiovascular disease (HR 1.24, 95% CI 1.11-1.39, p=<0.001). Among Black females, a breast cancer diagnosis was associated with a significantly higher risk of incident cardiovascular disease (unadjusted HR 1.24; 95% CI 1.11-1.39; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: